中国病理生理学会危重病医学专业委员会 |

[ICU Management & Practice]: Solidarity试验中期结果：新冠肺炎住院患者的抗病毒药物治疗

[陈德昌教授]: 1971年西藏阿里的

2021年04月16日 ⁄ 事件●关注, 学会动态

在日土县，总能有意外的发现。好几个世纪以来，西藏神权至上，耕地种青稞要触怒山神。就这么一道紧箍咒和套在藏民头上的那个该死的箍，社会发展停滞千年。荒唐的是解放前，西藏地方政府从印度进口粮食，专供地方政府各级官员和寺院神职人员享用。今天，时代改变了。在驻藏的汉族干部帮助下，昔日的奴隶，为了生存，他们组织农耕生产大队，15...

[ICU Management & Practice]: 新冠肺炎患者的高流量鼻导管氧疗与有创机械通气

High-flow Nasal Oxygen vs. Invasive Mechanical Ventilation in COVID-19 COVID-19 has caused thousands of cases of acute respiratory failure with a high mortality rate. However, so far, the use of high-flow nasal oxygen (HFNO) has been limited even though it may be an appropriate initial therapy in COVID-19 patien...

[JAMA发表论文]：伊维菌素对

2021年04月14日 ⁄ 时讯速递, 进展交流

Original Investigation March 4, 2021 Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial Eduardo López-Medina, Pío López, Isabel C. Hurtado, et al JAMA. Published online March 4, 2021. doi:10.1001/jama.2021.3071 Abstract I...

[JAMA在线发表]：氢化可的松

2020年09月11日 ⁄ 时讯速递, 进展交流

Original Investigation Caring for the Critically Ill PatientSeptember 2, 2020 Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial Pierre-François Dequin, Nicholas Heming, Ferhat Meziani, et al JAMA. Publ...

0℃

研究点评, 进展交流

[ICU Management & Practice]: Solidarity试验中期结果：新冠肺炎住院患者的抗病毒药物治疗

2021年04月17日 ⁄ 研究点评, 进展交流

2021年04月17日

Solidarity Trial Interim Results: Antiviral Drugs in Hospitalised COVID-19 Patients Mortality trials of four antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon beta-1a were recommended by the World Health Organization (WHO) to evaluate their effect in patients hospitalised with COVID-19. In March 2020, the WHO began a large international trial that included hospital inpatients to evaluate the effects of these four drugs on...

阅读全文